In this episode of The Pets Magazine Podcast, I’m joined by Dr Ilona Holcomb from ImpriMed, a pioneering biotech company based in Silicon Valley. ImpriMed is at the forefront of using artificial intelligence to personalise cancer treatment for pets – applying cutting-edge insights from human oncology to improve veterinary outcomes.
Dr Holcomb explains how AI-driven testing can help predict which therapies will work best for individual pets, saving precious time and improving quality of life for animals and their families. It’s a fascinating conversation about the future of cancer care, the emotional impact of diagnosis, and the exciting possibilities technology is unlocking in veterinary medicine.
If you’re passionate about pets, science or innovation, this is one not to miss.
